Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Mate, having considered the failure rate of phase 2/3 trials do...

First 39 Last

Share
Profile

Follow
ma420

6,298 Posts.

1578

19/10/20

15:20

Post #: 48206296
Share

Originally posted by FiSaver: ↑

Im sure that with normal drug development something like RWD would be a lot harder that's why trials are risky you go to do them find the answer (positive or negative) and then use it to inform next steps.

The SAS model and huge numbers taking up products is novel for cannabis drug discovery. The relationship with the clinical aspect surely will be driving this real-world data capture and early testing of what may/may not work and get good numbers while making potential $. Pretty novel in the drug discovery space and one that means you can rapidly spin up the waterwheel and then rapid learn and grow. while trials follow up at the end for cherry on the pie.

Cannabis market - $13B
Pharma market - $360B

% of global wealth - tangible assets? like 5%
% of global wealth - intangible - 95% (IP)

I know what pie I like.

Expand

Mate, having considered the failure rate of phase 2/3 trials do you see downside to SP below 10c?

IHL Price at posting: 9.2¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 2 more messages in this thread...

First 39 Last

Add IHL (ASX) to my watchlist